Literature DB >> 7356893

Factors determining the passage of drugs from blood into saliva.

K W Stephen, J McCrossan, D Mackenzie, C B Macfarlane, C F Speirs.   

Abstract

1. Following single oral dosing of ampicillin, cephalexin, tetracycline, erythromycin estolate, clindamycin and rifampicin to six normal volunteers, antibacterial activity was measured at 1, 3 and 6 h in serum, gingival fluid and minor gland saliva from all subjects and in parotid and submandiabular saliva from three. 2. pH values of all gingival fluid and saliva specimens were noted. 3. Partition coefficients between n-octanol and water were measured for erythromycin, clindamycin and rifampicin. Published data were used for ampicillin, cephalexin and tetracycline. 4. All antibiotics, but particularly rifampicin, were detected in gingival fluid. Only rifampicin and to a lesser degree, clindamycin were present in the other salivary constituents. 5. In studies of secretion of drugs in saliva, both the physico-chemical characteristics of the drugs and the physiological differences between individual salivary components should be considered. 6. Parotid saliva samples are likely to be of greatest value.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7356893      PMCID: PMC1429928          DOI: 10.1111/j.1365-2125.1980.tb04796.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  10 in total

1.  A system of classification and scoring for prevalence surveys of periodontal disease.

Authors:  A L RUSSELL
Journal:  J Dent Res       Date:  1956-06       Impact factor: 6.116

2.  Methods for collecting individual components of mixed saliva: the relevance to clinical pharmacology.

Authors:  K W Stephen; C F Speirs
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

Review 3.  Oral absorption and secretion of drugs.

Authors:  C F Speirs
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

4.  Acute septic parotitis: incidence, aetiology and management.

Authors:  C F Speirs; D K Mason
Journal:  Scott Med J       Date:  1972-02       Impact factor: 0.729

5.  pH-partition behavior of amino acid-like -lactam antibiotics.

Authors:  E D Purich; J L Colaizzi; R I Poust
Journal:  J Pharm Sci       Date:  1973-04       Impact factor: 3.534

6.  Antibacterial drugs for oral infections.

Authors:  C F Speirs; K W Stephen
Journal:  Br Dent J       Date:  1968-08-20       Impact factor: 1.626

7.  Parotid and whole saliva in the prediction of serum total and free phenytoin concentrations.

Authors:  S N Anavekar; R H Saunders; W M Wardell; I Shoulson; F G Emmings; C E Cook; A J Gringeri
Journal:  Clin Pharmacol Ther       Date:  1978-12       Impact factor: 6.875

8.  Comparison of human serum, parotid and mixed saliva levels of phenoxymethylpenicillin, ampicillin, cloxacillin and cephalexin.

Authors:  C F Speirs; D Stenhouse; K W Stephen; E T Wallace
Journal:  Br J Pharmacol       Date:  1971-09       Impact factor: 8.739

9.  pH-Partition behavior of tetracyclines.

Authors:  J L Colaizzi; P R Klink
Journal:  J Pharm Sci       Date:  1969-10       Impact factor: 3.534

10.  A study of the behavior of propionyl erythromycin in blood by a new chromatographic method.

Authors:  V C Stephens; C T Pugh; N E Davis; M M Hoehn; S Ralston
Journal:  J Antibiot (Tokyo)       Date:  1969-11       Impact factor: 2.649

  10 in total
  3 in total

Review 1.  Clinical pharmacokinetics of oral contraceptive steroids.

Authors:  M L Orme; D J Back; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1983 Mar-Apr       Impact factor: 6.447

2.  Detection of carbamazepine in saliva based on surface-enhanced Raman spectroscopy.

Authors:  Ning Chen; Yanbing Yuan; Ping Lu; Luyao Wang; Xuedian Zhang; Hui Chen; Pei Ma
Journal:  Biomed Opt Express       Date:  2021-11-18       Impact factor: 3.732

Review 3.  A Qualitative Review on the Pharmacokinetics of Antibiotics in Saliva: Implications on Clinical Pharmacokinetic Monitoring in Humans.

Authors:  Tony K L Kiang; Mary H H Ensom
Journal:  Clin Pharmacokinet       Date:  2016-03       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.